Scienture Holdings, Inc. (Nasdaq: SCNX) has entered into a securities purchase agreement to sell 3,225,000 shares of common stock at an offering price of $1.20 per share.
The gross proceeds from the offering are expected to be approximately $3.9 million.
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock at $1.20 per share, with gross proceeds of $3.9 million.
Placement Agent
Maxim Group LLC is acting as the sole placement agent for the offering.
Registration Statement
The offering is made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-289198) filed with the SEC on August 1, 2025.
- Scienture Holdings is raising funds through this registered direct offering to support its pharmaceutical operations.
- The offering will enable the company to enhance its market position and potentially develop and bring novel specialty products to market.
The successful completion of this offering signifies a positive step for Scienture Holdings, Inc. in strengthening its financial position and expanding its pharmaceutical product portfolio.